Metabolic Syndrome and Leptin Level Associated With Fructose Consumption in Spain
Sponsor
Hospital Mateo Orfila (Other)
Overall Status
Completed
CT.gov ID
NCT00651001
Collaborator
(none)
800
1
12
66.7
Study Details
Study Description
Brief Summary
A Food Frequency Questionnaire (FFQ), will be provided to 800 adults to assess overall fructose intake and this will be related to a number of features related to the metabolic syndrome, including serum leptin, characteristic features of metabolic syndrome (body mass index, waist circumference, plasma lipids, blood pressure, HOMA index,fasting glucose and fasting insulin levels) and other as: CRP, fibrinogen, homocysteine and uric acid.
Condition or Disease | Intervention/Treatment | Phase |
---|---|---|
|
Study Design
Study Type:
Observational
Anticipated Enrollment
:
800 participants
Observational Model:
Ecologic or Community
Time Perspective:
Cross-Sectional
Official Title:
Prevalence of Cardiovascular Risk Factors in Minorca - Spain
Study Start Date
:
Jun 1, 2008
Actual Primary Completion Date
:
Jan 1, 2009
Study Completion Date
:
Jun 1, 2009
Outcome Measures
Primary Outcome Measures
- Serum leptin levels as it relates to fructose intake [Epidemiological association]
Secondary Outcome Measures
- Relationship of metabolic syndrome features with fructose intake. This includes measuring all 5 components of metabolic syndrome, assessing insulin resistance by HOMA, and measuring some markers of inflammation (CRP, fibrinogen, homocysteine) [Epidemiological]
Eligibility Criteria
Criteria
Ages Eligible for Study:
18 Years
to 70 Years
Sexes Eligible for Study:
All
Accepts Healthy Volunteers:
Yes
Inclusion Criteria:
- Adults, 18-70 years of age
Exclusion Criteria:
-
Diabetes
-
Kidney Failure
-
Heart Failure
-
Cancer
Contacts and Locations
Locations
Site | City | State | Country | Postal Code | |
---|---|---|---|---|---|
1 | Renal Unit of Mateo Orfila Hospital, Balearic Islands - Spain | Menorca | Balearic Islands | Spain | 07703 |
Sponsors and Collaborators
- Hospital Mateo Orfila
Investigators
None specified.Study Documents (Full-Text)
None provided.More Information
Publications
None provided.Responsible Party:
,
,
ClinicalTrials.gov Identifier:
NCT00651001
Other Study ID Numbers:
- IbSalut-M-002
First Posted:
Apr 2, 2008
Last Update Posted:
Aug 6, 2009
Last Verified:
Aug 1, 2009
Keywords provided by ,
,
Additional relevant MeSH terms: